How the FDA is focused on improving clinical trial access, enrollment, and enhancing public trust and education
Update: 2021-12-15
Description
The U.S. population is growing increasingly diverse and ensuring that we have meaningful representation of racial and ethnic minorities and other diverse populations in clinical trials for regulated medical products is fundamental not only to FDA's regulatory mission, but also public health,” Dr. Jovonni Spinner, Associate Director of Outreach and Communications at the FDA's Office of Minority Health and Health Equity.
Related links
https://www.fda.gov/about-fda/office-commissioner/office-minority-health-and-health-equity
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
